FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W176071168> ?p ?o ?g. }

• W176071168 endingPage "780" @default.
• W176071168 startingPage "775" @default.
• W176071168 abstract "The calcitonin-calcitonin-gene-related peptide (CGRP) gene complex encodes a small family of peptides: calcitonin, CGRP and katacalcin. Calcitonin is a circulating hormone that prevents skeletal breakdown by inhibiting the resorption of bone by osteoclasts. CGRP, a potent vasodilator, is involved in normal regulation of blood flow. The calcitonins structurally resemble the CGRP peptides, and both are known to cross-react at each others' receptors. The present study was undertaken to examine the structural prerequisites for biological activity of the intact CGRP molecule. We therefore prepared eight chymotryptic and tryptic fragments of CGRP and synthesized its acetylated and S-carboxyamidomethylcysteinyl analogues. The analogues were purified by h.p.l.c. and their structures were confirmed by fast-atom bombardment mass spectrometry. We have examined the effects of structurally modified analogues and fragments of human CGRP in a calcitonin-receptor-mediated assay, the osteoclast bone resorption assay, and in one or two CGRP-receptor-mediated assays, the rabbit skin blood flow assay and the oedema formation assay. The results showed that (1) in the osteoclast bone resorption assay, both CGRP peptides, alpha and beta, were equipotent, and were both at least 1000-fold were both approx. 1000-fold more potent than salmon calcitonin; human calcitonin had no effect; (3) the bis- and N-acetylated CGRP analogues retained reduced levels of biological activity in all assays, whereas S-carboxyamidomethylcysteinyl-human CGRP was without activity; and (4) all tryptic and chymotryptic fragments of CGRP were without biological activity, with the exception of hCGRP-(Ala1-Lys35): this fragment had much reduced activity compared with the intact peptide in inhibiting osteoclastic bone resorption and increasing blood flow in the rabbit skin. The results suggest that: (1) calcitonin and CGRP act at distinct receptors to mediate different physiological effects; (2) minor amino acid substitutions, as between the alpha and beta forms of CGRP (these two forms have 94% structural similarity) do not result in differences in biological activity; (3) the intact peptide is required for full biological activity of the CGRP molecule, and even the loss of two amino acids at the C-terminus of the molecule results in a marked decrease in activity; (4) the disulphide bridge appears to play an important role in the interaction of the intact CGRP molecule with its receptor; and (5) the C-terminal region is probably necessary for the peptide to assume the right conformation in the interaction with the receptor." @default.
• W176071168 created "2016-06-24" @default.
• W176071168 creator A5003088187 @default.
• W176071168 creator A5004215185 @default.
• W176071168 creator A5009512362 @default.
• W176071168 creator A5025782791 @default.
• W176071168 creator A5026306331 @default.
• W176071168 creator A5029158702 @default.
• W176071168 creator A5069263649 @default.
• W176071168 creator A5073697395 @default.
• W176071168 date "1990-08-01" @default.
• W176071168 modified "2023-10-15" @default.
• W176071168 title "Structure-activity relationship of human calcitonin-gene-related peptide" @default.
• W176071168 cites W1509189642 @default.
• W176071168 cites W1512269500 @default.
• W176071168 cites W1974903230 @default.
• W176071168 cites W1977527684 @default.
• W176071168 cites W1988325008 @default.
• W176071168 cites W1988749057 @default.
• W176071168 cites W1999968337 @default.
• W176071168 cites W2004674974 @default.
• W176071168 cites W2005423274 @default.
• W176071168 cites W2012662719 @default.
• W176071168 cites W2012748943 @default.
• W176071168 cites W2015852167 @default.
• W176071168 cites W2018278119 @default.
• W176071168 cites W2025975898 @default.
• W176071168 cites W2035581625 @default.
• W176071168 cites W2046731801 @default.
• W176071168 cites W2048142673 @default.
• W176071168 cites W2052965227 @default.
• W176071168 cites W2053277833 @default.
• W176071168 cites W2054715973 @default.
• W176071168 cites W2061827641 @default.
• W176071168 cites W2069153618 @default.
• W176071168 cites W2070762250 @default.
• W176071168 cites W2072742112 @default.
• W176071168 cites W2075254495 @default.
• W176071168 cites W2082846352 @default.
• W176071168 cites W2087427200 @default.
• W176071168 cites W2152848856 @default.
• W176071168 cites W2158816358 @default.
• W176071168 cites W2224676279 @default.
• W176071168 cites W2404854699 @default.
• W176071168 cites W2413832517 @default.
• W176071168 cites W2417966299 @default.
• W176071168 doi "https://doi.org/10.1042/bj2690775" @default.
• W176071168 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1131654" @default.
• W176071168 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2390067" @default.
• W176071168 hasPublicationYear "1990" @default.
• W176071168 type Work @default.
• W176071168 sameAs 176071168 @default.
• W176071168 citedByCount "42" @default.
• W176071168 countsByYear W1760711682014 @default.
• W176071168 countsByYear W1760711682016 @default.
• W176071168 countsByYear W1760711682018 @default.
• W176071168 crossrefType "journal-article" @default.
• W176071168 hasAuthorship W176071168A5003088187 @default.
• W176071168 hasAuthorship W176071168A5004215185 @default.
• W176071168 hasAuthorship W176071168A5009512362 @default.
• W176071168 hasAuthorship W176071168A5025782791 @default.
• W176071168 hasAuthorship W176071168A5026306331 @default.
• W176071168 hasAuthorship W176071168A5029158702 @default.
• W176071168 hasAuthorship W176071168A5069263649 @default.
• W176071168 hasAuthorship W176071168A5073697395 @default.
• W176071168 hasBestOaLocation W1760711682 @default.
• W176071168 hasConcept C116073593 @default.
• W176071168 hasConcept C118303440 @default.
• W176071168 hasConcept C126322002 @default.
• W176071168 hasConcept C134018914 @default.
• W176071168 hasConcept C146562846 @default.
• W176071168 hasConcept C163170386 @default.
• W176071168 hasConcept C170493617 @default.
• W176071168 hasConcept C185592680 @default.
• W176071168 hasConcept C202751555 @default.
• W176071168 hasConcept C2776033226 @default.
• W176071168 hasConcept C2779281246 @default.
• W176071168 hasConcept C2779627488 @default.
• W176071168 hasConcept C55493867 @default.
• W176071168 hasConcept C673006 @default.
• W176071168 hasConcept C71924100 @default.
• W176071168 hasConcept C86803240 @default.
• W176071168 hasConcept C92316933 @default.
• W176071168 hasConceptScore W176071168C116073593 @default.
• W176071168 hasConceptScore W176071168C118303440 @default.
• W176071168 hasConceptScore W176071168C126322002 @default.
• W176071168 hasConceptScore W176071168C134018914 @default.
• W176071168 hasConceptScore W176071168C146562846 @default.
• W176071168 hasConceptScore W176071168C163170386 @default.
• W176071168 hasConceptScore W176071168C170493617 @default.
• W176071168 hasConceptScore W176071168C185592680 @default.
• W176071168 hasConceptScore W176071168C202751555 @default.
• W176071168 hasConceptScore W176071168C2776033226 @default.
• W176071168 hasConceptScore W176071168C2779281246 @default.
• W176071168 hasConceptScore W176071168C2779627488 @default.
• W176071168 hasConceptScore W176071168C55493867 @default.
• W176071168 hasConceptScore W176071168C673006 @default.
• W176071168 hasConceptScore W176071168C71924100 @default.

• next